4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-21-002612
Options or other derivatives
- Director acquired 20,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Kariv Tomer Director | 2021-05-19 | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | D: show line 1 in the form |
Loading xslF345X03/form4-05202021_040528.xml…